Home Other Building Blocks 77307-50-7
77307-50-7,MFCD09842349
Catalog No.:AA005CWN

77307-50-7 | SL 0101-1

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
≥95%
in stock  
$143.00   $100.00
- +
5mg
≥95%
in stock  
$565.00   $395.00
- +
10mg
≥95%
in stock  
$782.00   $547.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Literature
Technical Information
Catalog Number:
AA005CWN
Chemical Name:
SL 0101-1
CAS Number:
77307-50-7
Molecular Formula:
C25H24O12
Molecular Weight:
516.4509
MDL Number:
MFCD09842349
SMILES:
CC(=O)OC1[C@H](C)OC([C@@H](C1OC(=O)C)O)Oc1c(oc2c(c1=O)c(O)cc(c2)O)c1ccc(cc1)O
Properties
Properties
 
Form:
Solid  
MP:
140 - 147°C   
Storage:
Keep in dry area;-20 ℃;  

Computed Properties
 
Complexity:
909  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
5  
Heavy Atom Count:
37  
Hydrogen Bond Acceptor Count:
12  
Hydrogen Bond Donor Count:
4  
Rotatable Bond Count:
7  
XLogP3:
2.4  

Literature

Title: Insights into the inhibition of the p90 ribosomal S6 kinase (RSK) by the flavonol glycoside SL0101 from the 1.5 Å crystal structure of the N-terminal domain of RSK2 with bound inhibitor.

Journal: Biochemistry 20120821

Title: Spectaflavoside A, a new potent iron chelating dimeric flavonol glycoside from the rhizomes of Zingiber spectabile Griff.

Journal: Bioorganic & medicinal chemistry letters 20120601

Title: Analogs of the RSK inhibitor SL0101: optimization of in vitro biological stability.

Journal: Bioorganic & medicinal chemistry letters 20120501

Title: Differential mTOR and ERK pathway utilization by effector CD4 T cells suggests combinatorial drug therapy of arthritis.

Journal: Clinical immunology (Orlando, Fla.) 20120201

Title: SHAFTS: a hybrid approach for 3D molecular similarity calculation. 2. Prospective case study in the discovery of diverse p90 ribosomal S6 protein kinase 2 inhibitors to suppress cell migration.

Journal: Journal of medicinal chemistry 20110526

Title: Differential regulation of NHE1 phosphorylation and glucose uptake by inhibitors of the ERK pathway and p90RSK in 3T3-L1 adipocytes.

Journal: Cellular signalling 20091201

Title: Y-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cells.

Journal: Breast cancer research : BCR 20080101

Title: The selectivity of protein kinase inhibitors: a further update.

Journal: The Biochemical journal 20071215

Title: Structural basis for the activity of the RSK-specific inhibitor, SL0101.

Journal: Bioorganic & medicinal chemistry 20070715

Title: De novo asymmetric syntheses of SL0101 and its analogues via a palladium-catalyzed glycosylation.

Journal: Organic letters 20061026

Title: Influence of rhamnose substituents on the potency of SL0101, an inhibitor of the Ser/Thr kinase, RSK.

Journal: Bioorganic & medicinal chemistry 20060901

Title: Homology model of RSK2 N-terminal kinase domain, structure-based identification of novel RSK2 inhibitors, and preliminary common pharmacophore.

Journal: Bioorganic & medicinal chemistry 20060901

Title: Sesquiterpenes and flavonol glycosides from Zingiber aromaticum and their CYP3A4 and CYP2D6 inhibitory activities.

Journal: Journal of natural products 20040701

Title: Smith JA, et al. Identification of the first specific inhibitor of p90 ribosomal S6 kinase (RSK) reveals an unexpected role for RSK in cancer cell proliferation. Cancer Res. 2005 Feb 1;65(3):1027-34.

Title: Yu Li, et al. The Affinity of RSK for Cylitol Analogues of SL0101 Is Critically Dependent on the B-ring C-4'-hydroxy. Chem Commun (Camb). 2020 Mar 10;56(20):3058-3060.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:77307-50-7 Molecular Formula|77307-50-7 MDL|77307-50-7 SMILES|77307-50-7 SL 0101-1